Patents by Inventor Einar Sverre Berg

Einar Sverre Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF NONVIABLE PARTICLES COMPRISING AN INTERNAL CONTROL (IC) NUCLEIC ACID
    Publication number: 20110065092
    Abstract: The present invention relates to the use of non-viable particles (and in particular liposome particles, particles which are in the form of a viral protein coat, non-viable genetically modified organisms or particles made of synthetic polymers), comprising an internal control (IC) nucleic acid sequence as an internal control in nucleic acid-based analysis. The present invention further relates to non-viable particles comprising an IC nucleic acid and kits for carrying out the methods and uses of the invention.
    Type: Application
    Filed: September 10, 2010
    Publication date: March 17, 2011
    Applicant: IC PARTICLES AS
    Inventors: Einar Sverre BERG, Kjell SKAUG
  • Use
    Publication number: 20040101869
    Abstract: The present invention relates to the use of non-viable particles (and in particular liposome particles, particles which are in the form of a viral protein coat, non-viable genetically modified organisms or particles made of synthetic polymers), comprising an internal control (IC) nucleic acid sequence as an internal control in nucleic acid-based analysis. The present invention further relates to non-viable particles comprising an IC nucleic acid and kits for carrying out the methods and uses of the invention.
    Type: Application
    Filed: July 21, 2003
    Publication date: May 27, 2004
    Inventors: Einar Sverre Berg, Kjell Skaug
  • Internal control and method for surveillance of Gap-LCR
    Patent number: 6114155
    Abstract: A method for performing Gap-filling Ligase Chain Reaction (Gap-LCR) using an internal control which has been modified to contain a unique site for a restriction enzyme and which has approximately the same length and identical four LCR probe sites as the target nucleic acid.
    Type: Grant
    Filed: January 15, 1998
    Date of Patent: September 5, 2000
    Assignee: Statens Institutt for Folkehelse
    Inventors: Kjell Skaug, Einar Sverre Berg